{
    "id": "0227",
    "question": "A 62-year-old woman is evaluated because of a 3-day history of headache, nausea, and decreased urination. Laboratory studies show:\nSerum\nNa+ 136 mEq/L\nK+ 3.2 mEq/L\nCl- 115 mEq/L\nMg2+ 1.4 mEq/L\nUrine\npH 7.0\nArterial blood gas analysis on room air shows a pH of 7.28 and a HCO3- concentration of 14 mEq/L. Prolonged treatment with which of the following drugs would best explain this patient's findings?\"",
    "options": {
        "A": "Trimethoprim-sulfamethoxazole",
        "B": "Eplerenone",
        "C": "Amphotericin B",
        "D": "Heparin"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"To approach this question, we need to analyze the patient's symptoms and laboratory results to determine the underlying cause of her hyponatremia (low sodium level) and acidosis (low pH). The patient presents with headache, nausea, and decreased urination, which are non-specific symptoms that can be associated with various conditions. However, the laboratory results show a low sodium level (136 mEq/L), low potassium level (3.2 mEq/L), and metabolic acidosis (low pH of 7.28 and low HCO3- concentration of 14 mEq/L). The urine pH is also acidic (7.0). These findings suggest that the patient has a mixed disorder of hyponatremia and metabolic acidosis. The patient's symptoms and laboratory results do not suggest a primary renal cause of the hyponatremia, as the urine sodium level is not low (which would be expected in the setting of volume depletion or renal sodium wasting). Instead, the patient appears to have a central cause of the hyponatremia, which is consistent with the use of certain medications. Let's evaluate the potential choices: A. Trimethoprim-sulfamethoxazole: This antibiotic can cause a syndrome of inappropriate antidiuretic hormone secretion (SIADH), which leads to hyponatremia. However, SIADH is typically associated with a high urine sodium level, which is not present in this patient. B. Eplerenone: This is a potassium-sparing diuretic that can cause hyperkalemia (high potassium level), which is not present in this patient. Additionally, eplerenone is not typically associated with hyponatremia. C. Amphotericin B: This antifungal medication can cause nephrotoxicity, which can lead to renal failure and hyponatremia. Amphotericin B can also cause SIADH, which would explain the patient's hyponatremia and metabolic acidosis. The patient's symptoms of headache and nausea may also be consistent with amphotericin B-induced nephrotoxicity. D. Heparin: This anticoagulant is not typically associated with hyponatremia or metabolic acidosis. Based on the patient's symptoms and laboratory results, the most likely cause of her hyponatremia and metabolic acidosis is the use of amphotericin B. This medication can cause SIADH, leading to hyponatremia, and nephrotoxicity, leading to metabolic acidosis. answer_choice\": \"C\"}}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_3650",
            "title": "InternalMed_Harrison",
            "content": "A 44-year-old woman was referred from a local hospital after presenting with flaccid paralysis. Severe hypokalemia was documented (2.0 meq/L), and an infusion containing KCl was initiated. PART 2 Cardinal Manifestations and Presentation of Diseases Sodium 140 meq/L Potassium 2.6 meq/L Chloride 115 meq/L Bicarbonate 15 meq/L Anion gap 10 meq/L BUN 22 mg/dL Creatinine 1.4 mg/dL pH 7.32 U PaCO2 30 mmHg HCO3\u2212 15 meq/L Rheumatoid factor positive, anti-Ro/SS-A positive, and anti-La/SS-B positive pH = 6.0, normal sediment without white or red blood cell casts and no bacteria. The urine protein-to-creatinine ratio was 0.150 g/g. Urinary electrolyte values were: Na+ 35, K+ 40, Cl\u2212 18 meq/L. Therefore, the urine anion gap was positive, indicating low urine NH4+ excretion."
        },
        {
            "id": "InternalMed_Harrison_3631",
            "title": "InternalMed_Harrison",
            "content": "Na+ 120 K+ 4.3 Cl\u2212 89 HCO3\u2212 23 BUN 8 Creat 1.0 Glu 93 Alb 3.1 Ca 8.9 Phos 2.8 Mg 2.0 Plasma osm 248 mOsm/kg Cortisol 25 \u03bcg/dL TSH 2.6 Uric acid 2.7 mg/dL Urine: Na+ 97 K+ 22 Cl\u2212 86 Osm 597 The patient was treated with furosemide, 20 mg PO bid, and salt tablets. The plasma Na+ concentration increased to 129 meq/L with this therapy; however, the patient developed orthostatic hypotension and dizziness. He was started on demeclocycline, 600 mg PO in the morning and 300 mg in the evening, just before discharge from hospital. Plasma Na+ concentration increased to 140 meq/L with a BUN of 23 and creatinine of 1.4, at which point demeclocycline was reduced to 300 mg PO bid. Bronchoscopic biopsy eventually showed small-cell lung cancer; the patient declined chemotherapy and was admitted to hospice. What factors contributed to this patient\u2019s hyponatremia? What are the therapeutic options?"
        },
        {
            "id": "InternalMed_Harrison_3685",
            "title": "InternalMed_Harrison",
            "content": "A stuporous 22-year-old man was admitted with a history of behaving strangely. His friends indicated he experienced recent emotional problems stemming from a failed relationship and had threatened suicide. There was a history of alcohol abuse, but his friends were unaware of recent alcohol consumption. The patient was obtunded on admission, with no evident focal neurologic deficits. The remainder of the physical examination was unremarkable. Na+ 140 meq/L K+ 5 meq/L Cl\u2212 95 meq/L HCO3\u2212 10 meq/L Glucose 125 mg/dL BUN 15 mg/dL Creatinine 0.9 mg/dL Ionized calcium 4.0 mg/dL Plasma osmolality 325 mOsm kg/H2O Urinalysis revealed crystalluria, with a mixture of envelope-shaped and needle-shaped crystals."
        },
        {
            "id": "InternalMed_Harrison_3597",
            "title": "InternalMed_Harrison",
            "content": "Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples David B. Mount, Thomas D. DuBose, Jr. CASE 1 64e A 23-year-old woman was admitted with a 3-day history of fever, cough productive of blood-tinged sputum, confusion, and orthostasis. Past medical history included type 1 diabetes mellitus. A physical examination in the emergency department indicated postural hypo-tension, tachycardia, and Kussmaul respiration. The breath was noted to smell of \u201cacetone.\u201d Examination of the thorax suggested consolidation in the right lower lobe. Sodium 130 meq/L Potassium 5.0 meq/L Chloride 96 meq/L CO2 14 meq/L Blood urea nitrogen (BUN) 20 mg/dL Creatinine 1.3 mg/dL Glucose 450 mg/dL Pneumonic infiltrate, right lower lobe The diagnosis of the acid-base disorder should proceed in a stepwise fashion: 1. The normal anion gap (AG) is 8\u201310 meq/L, but in this case, the AG is elevated (20 meq/L). Therefore, the change in AG (\u0394AG) = ~10 meq/L. 2."
        },
        {
            "id": "InternalMed_Harrison_3628",
            "title": "InternalMed_Harrison",
            "content": "For this patient, the CeH2O was 2.5 L/d when initially evaluated, i.e., with urine Na+ and K+ concentrations of 34 and 5.2 meq/L, plasma Na+ concentration of 150 meq/L, and a urinary volume of 3.4 L. Therefore, the patient was given 2.5 L of D5W over the first 24 h to replace ongoing free water losses, along with 2.1 L of D5W to replace half his free water deficit. Daily random urine electrolytes and urinary volume measurement can be used to monitor CeH2O and adjust daily fluid administration in this manner, while following plasma Na+ concentration. Physicians often calculate the free water deficit to guide therapy of hypernatremia, providing half the deficit in the first 24 h. This approach can be adequate in patients who do not have significant ongoing losses of free water, e.g., with hypernatremia due to decreased free water intake. This case illustrates how free water requirements can be grossly underestimated in hypernatremic patients if ongoing, daily free water losses are not"
        },
        {
            "id": "InternalMed_Harrison_3617",
            "title": "InternalMed_Harrison",
            "content": "A 63-year-old man was admitted to the intensive care unit (ICU) with a severe aspiration pneumonia. Past medical history included schizophrenia, for which he required institutional care; treatment had included neuroleptics and intermittent lithium, the latter restarted 6 months before admission. The patient was treated with antibiotics and intubated for several days, with the development of polyuria (3\u20135 L/d), hypernatremia, and acute renal insufficiency; the peak plasma Na+ concentration was 156 meq/L, and peak creatinine was 2.6 mg/dL. Urine osmolality was measured once and reported as 157 mOsm/kg, with a coincident plasma osmolality of 318 mOsm/kg. Lithium was stopped on admission to the ICU. On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W."
        },
        {
            "id": "Physiology_Levy_3637",
            "title": "Physiology_Levy",
            "content": "8. How do the kidneys produce new HCO3 \u2212? 9. How is ammonium produced by the kidneys, and how does its excretion contribute to renal acid excretion? 10. What are the major mechanisms by which the body defends itself against changes in acid-base balance? 11. What are the differences between simple metabolic and respiratory acid-base disorders, and how are they differentiated by arterial blood gas measurements? he concentration of H+ in body fluids is low compared with that of other ions. For example, Na+ is present at a concentration some three million times greater than that of H+ ([Na+] = 140 mEq/L; [H+] = 40 nEq/L). Because of the low [H+] of the body fluids, it is commonly expressed as the negative logarithm, or pH."
        },
        {
            "id": "InternalMed_Harrison_3649",
            "title": "InternalMed_Harrison",
            "content": "Creatinine (mg/dL) 1.2 2.35 2.10 2.02 1.97 1.79 1.53 1.20 1.13 days after DDAVP administration. It is 64e-6 conceivable that residual hypovolemic hyponatremia attenuated the recovery of the plasma Na+ concentration. Alternatively, attenuated recovery was due to persistent effects of the single dose of DDAVP. Of note, although the plasma half-life of DDAVP is only 1\u20132 h, pharmacodynamic studies indicate a much more prolonged effect on urine output and/or urine osmolality. One final consideration is the effect of the patient\u2019s initial renal dysfunction on the pharmacokinetics and pharmacodynamics of the administered DDAVP, which is renally excreted; DDAVP should be administered with caution for the reinduction of hyponatremia in patients with chronic kidney disease or acute renal dysfunction. A 44-year-old woman was referred from a local hospital after presenting with flaccid paralysis. Severe hypokalemia was documented (2.0 meq/L), and an infusion containing KCl was initiated."
        },
        {
            "id": "InternalMed_Harrison_3642",
            "title": "InternalMed_Harrison",
            "content": "The plasma Na+ concentration on admission was 113 meq/L, with a creatinine of 2.35 (Table 64e-1). At hospital hour 7, the plasma Na+ concentration was 120 meq/L, potassium 5.4 meq/L, chloride 90 64e-5 meq/L, bicarbonate 22 meq/L, BUN 32 mg/dL, creatinine 2.02 mg/dL, glucose 89 mg/dL, total protein 5.0, and albumin 1.9. The hematocrit was 33.9, white count 7.6, and platelets 405. A morning cortisol was 19.5, with thyroid-stimulating hormone (TSH) of 1.7. The patient was treated with 1 \u03bcg of intravenous DDAVP, along with 75 mL/h of intravenous half-normal saline. After the plasma Na+ concentration dropped to 116 meq/L, intravenous fluid was switched to normal saline at the same infusion rate. The subsequent results are shown in Table 64e-1."
        },
        {
            "id": "InternalMed_Harrison_3678",
            "title": "InternalMed_Harrison",
            "content": "The patient presented with a mixed acid-base disorder, with a significant metabolic alkalosis and a bicarbonate concentration of 44 meq/L. A venous blood gas was drawn soon after his presentation; venous and arterial blood gases demonstrate a high level of agreement in hemodynamically stable patients, allowing for the interpretation of acid-base disorders with venous blood gas results. In response to his metabolic alkalosis, the Pco2 should have increased by 0.75 mmHg for each 1-meq/L increase in bicarbonate; the expected Pco2 should have been ~55 mmHg. Given the Pco2 of 62 mmHg, he had an additional respiratory acidosis, likely caused by respiratory muscle weakness from his acute hypokalemia and subacute hypercortisolism."
        },
        {
            "id": "InternalMed_Harrison_32553",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: P, plasma; RC, red cells; S, serum; WB, whole blood. Electrolytes Sodium 137\u2013145 mmol/L 137\u2013145 meq/L Potassium 2.7\u20133.9 mmol/L 2.7\u20133.9 meq/L Calcium 1.0\u20131.5 mmol/L 2.1\u20133.0 meq/L Magnesium 1.0\u20131.2 mmol/L 2.0\u20132.5 meq/L Chloride 116\u2013122 mmol/L 116\u2013122 meq/L CO2 content 20\u201324 mmol/L 20\u201324 meq/L PCO2 6\u20137 kPa 45\u201349 mmHg pH 7.31\u20137.34 Glucose 2.22\u20133.89 mmol/L 40\u201370 mg/dL Lactate 1\u20132 mmol/L 10\u201320 mg/dL Total protein: Lumbar 0.15\u20130.5 g/L 15\u201350 mg/dL Cisternal 0.15\u20130.25 g/L 15\u201325 mg/dL Ventricular 0.06\u20130.15 g/L 6\u201315 mg/dL Albumin 0.066\u20130.442 g/L 6.6\u201344.2 mg/dL IgG 0.009\u20130.057 g/L 0.9\u20135.7 mg/dL IgG indexb 0.29\u20130.59 Oligoclonal bands (OGB) <2 bands not present in matched serum sample"
        },
        {
            "id": "InternalMed_Harrison_27954",
            "title": "InternalMed_Harrison",
            "content": "3. Assess: Serum electrolytes (K+, Na+, Mg2+, Cl\u2212, bicarbonate, phosphate) Acid-base status\u2014pH, HCO3\u2212, PCO2, \u03b2-hydroxybutyrate Renal function (creatinine, urine output) 4. Replace fluids: 2\u20133 L of 0.9% saline over first 1\u20133 h (10\u201320 mL/kg per hour); subsequently, 0.45% saline at 250\u2013500 mL/h; change to 5% glucose and 0.45% saline at 150\u2013250 mL/h when plasma glucose reaches 250 mg/dL (13.9 mmol/L). 5. Administer short-acting insulin: IV (0.1 units/kg), then 0.1 units/kg per hour by continuous IV infusion; increase twoto threefold if no response by 2\u20134 h. If the initial serum potassium is <3.3 mmol/L (3.3 meq/L), do not administer insulin until the potassium is corrected. 6. Assess patient: What precipitated the episode (noncompliance, infection, trauma, pregnancy, infarction, cocaine)? Initiate appropriate workup for precipitating event (cultures, CXR, ECG). 7."
        },
        {
            "id": "InternalMed_Harrison_3630",
            "title": "InternalMed_Harrison",
            "content": "A 78-year-old man was admitted with pneumonia and hyponatremia. Plasma Na+ concentration was initially 129 meq/L, decreasing within 3 days to 118\u2013120 meq/L despite fluid restriction to 1 L/d. A chest computed tomography (CT) revealed a right 2.8 \u00d7 1.6 cm infrahilar mass and postobstructive pneumonia. The patient was an active smoker. Past medical history was notable for laryngeal carcinoma treated 15 years prior with radiation therapy, renal cell carcinoma, peripheral vascular disease, and hypothyroidism. On review of systems, he denied headache, nausea, and vomiting. He had chronic hip pain, managed with acetaminophen with codeine. Other medications included cilostazol, amoxicillin/clavulanate, digoxin, diltiazem, and thyroxine. He was euvolemic on examination, with no lymphadenopathy and a normal chest examination. Na+ 120 K+ 4.3 Cl\u2212 89 HCO3\u2212 23 BUN 8 Creat 1.0 Glu 93 Alb 3.1 Ca 8.9 Phos 2.8 Mg 2.0 Plasma osm 248 mOsm/kg Cortisol 25 \u03bcg/dL TSH 2.6 Uric acid 2.7 mg/dL"
        },
        {
            "id": "InternalMed_Harrison_27955",
            "title": "InternalMed_Harrison",
            "content": "6. Assess patient: What precipitated the episode (noncompliance, infection, trauma, pregnancy, infarction, cocaine)? Initiate appropriate workup for precipitating event (cultures, CXR, ECG). 7. Measure capillary glucose every 1\u20132 h; measure electrolytes (especially K+, bicarbonate, phosphate) and anion gap every 4 h for first 24 h. 8. Monitor blood pressure, pulse, respirations, mental status, fluid intake and output every 1\u20134 h. 9. Replace K+: 10 meq/h when plasma K+ <5.0\u20135.2 meq/L (or 20\u201330 meq/L of infusion fluid), ECG normal, urine flow and normal creatinine documented; administer 40\u201380 meq/h when plasma K+ <3.5 meq/L or if bicarbonate is given. If initial serum potassium is >5.2 mmol/L (5.2 meq/L), do not supplement K+ until the potassium is corrected. 10. See text about bicarbonate or phosphate supplementation. 11."
        },
        {
            "id": "InternalMed_Harrison_3683",
            "title": "InternalMed_Harrison",
            "content": "This case illustrates the difficulty in predicting the whole-body deficit of K+ in hypokalemic patients. In the absence of abnormal K+ redistribution, the total deficit correlates with plasma K+ concentration, which drops by approximately 0.27 mM for every 100-mmol reduction in total-body stores; this would suggest a deficit of ~650 meq of K+ in this patient, at the admission plasma K+ concentration of 1.7 meq/L. Notably, however, alkalemia induces a modest intracellular shift of circulating K+ such that this patient\u2019s initial plasma K+ concentration was not an ideal indicator of the total potassium deficit. Regardless of the underlying pathophysiology in this case, close monitoring of plasma K+ concentration is always essential during the correction of severe hypokalemia in order to gauge the adequacy of repletion and to avoid overcorrection."
        },
        {
            "id": "InternalMed_Harrison_3665",
            "title": "InternalMed_Harrison",
            "content": "Potassium 3.7 1.7 3.5 meq/L 7.47 Creatinine 2.8 2.9 2.3 mg/dL Magnesium 1.3 1.6 2.4 mg/dL Albumin 3.4 2.8 2.3 Total bilirubin 0.65 5.19 5.5 Abbreviations: ACTH, adrenocorticotropic hormone; HD2, hospital day 2; PTA, prior to admission. The patient\u2019s hospital course was complicated by acute respiratory failure attributed to pulmonary embolism; he died 2 weeks after admission. Why was this patient hypokalemic? Why was he weak? Why did he have an alkalosis? This patient suffered from metastatic small-cell lung cancer, which was persistent despite several rounds of chemotherapy and radiotherapy. He presented with profound hypokalemia, alkalosis, hypertension, severe weakness, jaundice, and worsening liver function tests."
        },
        {
            "id": "InternalMed_Harrison_3598",
            "title": "InternalMed_Harrison",
            "content": "The normal anion gap (AG) is 8\u201310 meq/L, but in this case, the AG is elevated (20 meq/L). Therefore, the change in AG (\u0394AG) = ~10 meq/L. 2. Compare the \u0394AG and the \u0394[HCO3\u2212]. In this case, the \u0394AG, as noted above, is 10, and the \u0394[HCO3\u2212] (25 \u2013 14) is 11. Therefore, the increment in the AG is approximately equal to the decrement in bicarbonate. 3. Estimate the respiratory compensatory response. In this case, the predicted Paco2 for an [HCO3\u2212] of 14 should be approximately 29 mmHg. This value is obtained by adding 15 to the measured [HCO3\u2212] (15 + 14 = 29) or by calculating the predicted Paco2 from the Winter equation: 1.5 \u00d7 [HCO3\u2212] + 8. In either case, the predicted value for Paco2 of 29 is significantly higher than the measured value of 24. Therefore, the prevailing Paco2 exceeds the range for compensation alone and is too low, indicating a superimposed respiratory alkalosis. 4."
        },
        {
            "id": "InternalMed_Harrison_3800",
            "title": "InternalMed_Harrison",
            "content": "The diagnosis of respiratory alkalosis depends on measurement of arterial pH and Paco2. The plasma [K+] is often reduced and the [Cl-] increased. In the acute phase, respiratory alkalosis is not associated with increased renal HCO3 excretion, but within hours net acid excretion is reduced. In general, the HCO3 concentration falls by 2.0 mmol/L for each 10-mmHg decrease in Paco2. Chronic hypocapnia reduces the serum [HCO3 -] by 4.0 mmol/L for each 10-mmHg decrease in Paco2. It is unusual to observe a plasma HCO3 <12 mmol/L as a result of a pure respiratory alkalosis. When a diagnosis of respiratory alkalosis is made, its cause should be investigated. The diagnosis of hyperventilation syndrome is made by exclusion. In difficult cases, it may be important to rule out other conditions such as pulmonary embolism, coronary artery disease, and hyperthyroidism."
        },
        {
            "id": "InternalMed_Harrison_3618",
            "title": "InternalMed_Harrison",
            "content": "On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W. After 3 days of intravenous hydration, a water deprivation test was performed. A single dose of 2 \u03bcg IV desmopressin (DDAVP) was given at 9 h (+9): Why did the patient develop hypernatremia, polyuria, and acute renal insufficiency? What does the water deprivation test demonstrate? What is the underlying pathophysiology of this patient\u2019s hypernatremic syndrome?"
        },
        {
            "id": "InternalMed_Harrison_3739",
            "title": "InternalMed_Harrison",
            "content": "Controversy exists, however, in regard to the use of alkali in patients with a pure AG acidosis owing to accumulation of a metabolizable organic acid anion (ketoacidosis or lactic acidosis). In general, severe acidosis (pH <7.10) warrants the IV administration of 50\u2013100 meq of NaHCO3, over 30\u201345 min, during the initial 1\u20132 h of therapy. Provision of such modest quantities of alkali in this situation seems to provide an added measure of safety, but it is essential to monitor plasma electrolytes during the course of therapy, because the [K+] may decline as pH rises. The goal is to increase the [HCO3 -] to 10 meq/L and the pH to approximately 7.20, not to increase these values to normal. PART 2 Cardinal Manifestations and Presentation of Diseases APPROACH TO THE PATIENT:"
        },
        {
            "id": "InternalMed_Harrison_3656",
            "title": "InternalMed_Harrison",
            "content": "A 32-year-old man was admitted to the hospital with weakness and hypokalemia. The patient had been very healthy until 2 months previously when he developed intermittent leg weakness. His review of systems was otherwise negative. He denied drug or laxative abuse and was on no medications. Past medical history was unremarkable, with no history of neuromuscular disease. Family history was notable for a sister with thyroid disease. Physical examination was notable only for reduced deep tendon reflexes. Sodium 139 143 meq/L Potassium 2.0 3.8 meq/L Chloride 105 107 meq/L Bicarbonate 26 29 meq/L BUN 11 16 mg/dL Creatinine 0.6 1.0 mg/dL Calcium 8.8 8.8 mg/dL Phosphate 1.2 mg/dL Albumin 3.8 meq/L TSH 0.08 \u03bcIU/L (normal 0.2\u20135.39) Free T4 41 pmol/L (normal 10\u201327)"
        },
        {
            "id": "Obstentrics_Williams_4132",
            "title": "Obstentrics_Williams",
            "content": "TABLE 32-3. Umbilical Cord Blood pH and Blood Gas Values in Normal Term Newborns Ramin, 1989a Riley, 1993b Kotaska, 201 Ob Kotaska, 2010e pH 7.28 (0.07) 7.27 (0.069) 7.26 (7.01n-7.39) 7.3 (7.05-7.39) Pco2 (mm Hg) 49.9 (14.2) 50.3(11n.1) 51 (30.9-85.8) 54 (37.5-79.5) HC03 -(mEq/L) 23.1 (2.8) 22.0 (3.6) Base excess (mEq/L) -3.6 (2.8) -2.7 (2.8) pH 7.34 (0.063) 7.31 (7.06-7.44) 7.34 (7.10-7.42) PC02 (mm Hg) 40.7 (7.9) 41 (24.9-70.9) 44 (29.1n-70.2) HC03 -(mEq/L) 21.4 (2.5) Base excess (mEq/L) -2.4 (2) aNewborns of selected women with uncomplicated vaginal deliveries. bNewborns of unselected women with vaginal deliveries. (Data shown as mean (SO). dOata shown as range with 2.5 or 97.5 percentile. eCesarean delivery-labor not stated. From Centers for Disease Control and Prevention, 201n2; Watson, 2006."
        },
        {
            "id": "InternalMed_Harrison_3783",
            "title": "InternalMed_Harrison",
            "content": "If associated conditions preclude infusion of saline, renal HCO3 loss can be accelerated by administration of acetazolamide, a carbonic anhydrase inhibitor, which is usually effective in patients with adequate renal function but can worsen K+ losses. Dilute hydrochloric acid (0.1 N HCl) is also effective but can cause hemolysis, and must be delivered slowly in a central vein. Respiratory acidosis can be due to severe pulmonary disease, respiratory muscle fatigue, or abnormalities in ventilatory control and is recognized by an increase in Paco2 and decrease in pH (Table 66-7). In acute respiratory acidosis, there is an immediate compensatory elevation (due to cellular buffering mechanisms) in HCO3 -, which increases 1 mmol/L for every 10-mmHg increase in Paco2. In chronic respiratory acidosis (>24 h), renal adaptation increases the [HCO3 -] by 4 mmol/L for every 10-mmHg increase in Paco2. The serum HCO3 usually does not increase above 38 mmol/L."
        },
        {
            "id": "Pharmacology_Katzung_6367",
            "title": "Pharmacology_Katzung",
            "content": "Michael J. Kosnett, MD, MPH Following Sunday morning services, 27 people attended a church social where coffee, baked goods, and sandwiches were served. Within 15\u201360 minutes, 13 people developed vomiting and abdominal discomfort, accompanied over the next several hours by nonbloody diarrhea. Within 12 hours, seven of these individuals were hospitalized with ongoing gastrointestinal symptoms, hypotension, and anion gap metabolic acidosis. Fluid resuscitation and pressors were accompanied by adequate urine output. What diagnoses should be considered? What tests should be conducted, and what therapy should be considered?"
        },
        {
            "id": "Physiology_Levy_3283",
            "title": "Physiology_Levy",
            "content": "WaterL/day1801.5178.599.2Na+ mEq/day25,20015025,05099.4K+ mEq/day72010062086.1Ca++ mEq/day5401053098.2HCO3\u2212 mEq/day43202431899.9+ Cl\u2212 mEq/day18,00015017,85099.2Glucosemmol/day8000800100.0Ureag/day56282850.0 aThe filtered amount of any substance is calculated by multiplying the concentration of that substance in the ultrafiltrate by the glomerular filtration rate (GFR); for example, the filtered load of Na+ is calculated as [Na+]ultrafiltrate (140mEq/L) \u00d7 GFR (180L/day) = 25,200mEq/day. The composition and volume of urine can vary widely in the healthy state. These values represent average ranges. Normal water excretion typically ranges between 0.5 and 1.5L/day.Data from Valtin HV. Renal Physiology. 2nd ed. Boston: Little, Brown; 1983."
        },
        {
            "id": "Pediatrics_Nelson_719",
            "title": "Pediatrics_Nelson",
            "content": "Potassium: 25 mEq/L Bicarbonate: 15 mEq/L Sodium: 60 mEq/L Solution: normal saline + 10 mEq/L potassium chloride Replace output mL/mL every 1\u20136 hr Potassium: 10 mEq/L Chloride: 90 mEq/L Place the patient on insensible Place the patient on insensible fluids (\u2153 maintenance) fluids (\u2153 maintenance) Replace urine output mL/mL Measure urine electrolytes with half normal saline Replace urine output mL/mL with a solution that is based on the measured urine electrolytes"
        },
        {
            "id": "Neurology_Adams_4475",
            "title": "Neurology_Adams",
            "content": "A fall in serum sodium to 125 mEq/L usually has few clinical effects, although signs of an associated neurologic disease, such as a previous stroke or a subdural hematoma, may worsen. Sodium levels of less than 120 mEq/L are attended by nausea and vomiting, inattentiveness, drowsiness, stupor, and generalized seizures. There may be asterixis. As is characteristic of most metabolic encephalopathies, the more rapid the decline of the serum sodium, the more likely there will be accompanying neurologic symptoms."
        },
        {
            "id": "InternalMed_Harrison_3735",
            "title": "InternalMed_Harrison",
            "content": "Similarly, normal values for [HCO3 -], Paco2, and pH do not ensure the absence of an acid-base disturbance. For instance, an alcoholic who has been vomiting may develop a metabolic alkalosis with a pH of 7.55, Paco2 of 47 mmHg, [HCO3 -] of 40 mmol/L, [Na+] of 135, [Cl-] of 80, and [K+] of 2.8. If such a patient were then to develop a superimposed alcoholic ketoacidosis with a \u03b2-hydroxybutyrate concentration of 15 mM, arterial pH would fall to 7.40, [HCO3 -] to 25 mmol/L, and the Paco2 to 40 mmHg. Although these blood gases are normal, the AG is elevated at 30 mmol/L, indicating a mixed metabolic alkalosis and metabolic acidosis. A mixture of high-gap acidosis and metabolic alkalosis is recognized easily by comparing the differences (\u2206 values) in the normal to prevailing patient values. In this example, the \u2206HCO3 is 0 (25 25 mmol/L), but the \u2206AG is 20 (30 \u2013 10 mmol/L). Therefore, 20 mmol/L is unaccounted for in the \u2206/\u2206 value (\u2206AG to \u2206HCO3 -)."
        },
        {
            "id": "InternalMed_Harrison_3664",
            "title": "InternalMed_Harrison",
            "content": "A 66-year-old man was admitted to hospital with a plasma K+ concentration of 1.7 meq/L and profound weakness. The patient had noted progressive weakness over several days, to the point that he was unable to rise from bed. Past medical history was notable for small-cell lung cancer with metastases to brain, liver, and adrenals. The patient had been treated with one cycle of cisplatin/etoposide 1 year before this admission, which was complicated by acute kidney injury (peak creatinine of 5, with residual chronic kidney disease), and three subsequent cycles of cyclophosphamide/doxorubicin/vincristine, in addition to 15 treatments with whole-brain radiation. On physical examination, the patient was jaundiced. Blood pressure was 130/70 mmHg, increasing to 160/98 mmHg after 1 L of saline, with a JVP at 8 cm. There was generalized muscle weakness. Potassium 3.7 1.7 3.5 meq/L 7.47 Creatinine 2.8 2.9 2.3 mg/dL Magnesium 1.3 1.6 2.4 mg/dL Albumin 3.4 2.8 2.3 Total bilirubin 0.65 5.19 5.5"
        },
        {
            "id": "InternalMed_Harrison_3626",
            "title": "InternalMed_Harrison",
            "content": "How should this patient be treated? What are the major pitfalls of therapy? This patient developed severe hypernatremia due to a water diuresis from lithium-associated NDI. Treatment of hypernatremia must include both replacement of the existing free water deficit and daily replacement of ongoing free water loss. The first step is to estimate total-body water (TBW), typically estimated as 50% of the body weight in women and 60% in men. The free water deficit is then calculated as ([Na+ \u2212 140]/140) \u00d7 TBW. In this patient, the free water deficit was 4.2 L at a weight of 97.5 kg and plasma Na+ concentration of 150 meq/L. This free water deficit should be replaced slowly over 48\u201372 h to avoid increasing the plasma Na+ concentration by >10 meq/L per 24 h. A common mistake is to replace this deficit while neglecting to replace ongoing losses of free water, such that plasma Na+ concentration either fails to correct or, in fact, increases."
        },
        {
            "id": "Surgery_Schwartz_599",
            "title": "Surgery_Schwartz",
            "content": "signs, such as a decrease in skin turgor and sunken eyes, in addition to cardiovascular and central nervous system signs (Table 3-2). Laboratory examination may reveal an elevated BUN level if the deficit is severe enough to reduce glomerular filtration and hemoconcentration. Urine osmolality usually will be higher than serum osmolality, and urine sodium will be low, typically <20 mEq/L. Serum sodium concentration does not necessar-ily reflect volume status and therefore may be high, normal, or low when a volume deficit is present. The most common cause of volume deficit in surgical patients is a loss of GI flu-ids (Table 3-3) from nasogastric suction, vomiting, diarrhea, or Figure 3-2. Chemical composition of body fluid compartments.PlasmaCATIONS154 mEq/L154 mEq/LCI\u2212SO42\u2013PO43\u2013ProteinOrganicacids103HCO3\u2212273516Na+142K+4Ca2+5Mg2+3ANIONSInterstitialfluidCATIONS153 mEq/L153 mEq/LCI\u2212PO43\u2013SO42\u2013ProteinOrganicacids114HCO3\u221230531Na+144K+4Ca2+3Mg2+2ANIONSIntracellularfluidCATIONS200 mEq/L200"
        },
        {
            "id": "InternalMed_Harrison_3644",
            "title": "InternalMed_Harrison",
            "content": "The initial hypovolemia increased the sensitivity of this patient\u2019s AVP response to osmolality, both decreasing the osmotic threshold for AVP release and increasing the slope of the osmolality response curve. AVP has a half-life of only 10\u201320 min; therefore, the acute increase in intravascular volume after a liter of intravenous saline led to a rapid reduction in circulating AVP. The ensuing water diuresis is the primary explanation for the rapid increase in plasma Na+ concentration in the first 7 h of her hospitalization."
        }
    ],
    "scores": [
        0.029235942462170747,
        0.02821202688830756,
        0.027245129997423578,
        0.02684633261769777,
        0.02350480752542608,
        0.02326284826284826,
        0.022861828094386236,
        0.022737530317410104,
        0.022604473619063592,
        0.022257175580579047,
        0.01935657865607257,
        0.018883049790683174,
        0.018499573742540493,
        0.018350930115636,
        0.01674971882841361,
        0.0167075831969449,
        0.016102551149280123,
        0.015953453453453455,
        0.015882019285309135,
        0.0158033890157433,
        0.015449773323789072,
        0.015283355644801428,
        0.014928698752228164,
        0.014775668679896463,
        0.01443089430894309,
        0.01438008130081301,
        0.014345794392523363,
        0.014304915514592934,
        0.014134452102687045,
        0.0139817911557042,
        0.013612056392805057,
        0.013555555555555557
    ]
}